What's new with us

Stay updated by reading our latest news

We work hard with cancer clinics, research institutes and life sciences partners to provide each cancer patient with more personalised care. Read more below.

Latest Updates

Kaiku Health, Oulu University Hospital and Vaasa Central Hospital to present research at ESMO Congress 2021

Kaiku Health, together with Oulu University Hospital and Vaasa Central Hospital, presents research at the virtual ESMO Congress 2021. The research investigates how ePRO follow-up affects patient care of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy. According to the results, ePRO follow-up was found to be good with 98% of the patients suggesting that the...

Read the article

Katariina Kronholm joins Kaiku Health as the new CCO

Kaiku Health adds more expertise in life sciences and international business development to the leadership team by welcoming Katariina Kronholm as the new Chief Commercial Officer.  Katariina has over a decade of experience helping senior leaders design and deliver complex business transformations across multiple geographies with a focus on life sciences and healthcare. As a...

Read the article

Kaiku Health to present research with Docrates Cancer Center and Hirslanden Institut für Radiotherapie at ESTRO 2021

New research by Kaiku Health, Docrates Cancer Center, and Hirslanden Institut für Radiotherapie Aarau will be presented at ESTRO 2021 as a poster discussion. This year, the congress is organized as a hybrid event and the poster session takes place online. Presented by Juha Kononen from Docrates Cancer Center, the poster shares insights into the...

Read the article

Electronic patient‑reported outcomes and machine learning in predicting immune‑related adverse events of immune checkpoint inhibitor therapies

Deep learning systems have widely presented promising results in cancer diagnostics [1] and for Kaiku Health, machine learning (ML) based approaches are not anything new. Previously, Oulu University Hospital (OYS) and Kaiku Health have shown that it is possible to predict both symptom and adverse event onset and continuation in patients receiving immune checkpoint inhibitor...

Read the article

Kaiku Health to develop digital patient monitoring for melanoma with leading global medicines company

Kaiku Health, the developer of digital health intervention platform in oncology, today announced it will develop digital patient monitoring and management for melanoma patients in collaboration with Novartis, a leading global medicines company. Melanoma is less common than other types of skin cancer, but it can more easily spread to other parts of the body....

Read the article

Follow us on social platforms

Media contact

Ellen Nurmi
+358 445512744


Get in touch with us

Interested in learning more about Kaiku Health? Send us a note